DLEU2 and cancer: In liver cancer caused by hepatitis B, HBX competes with EZH2 to bind to DLEU2, forming a complex that binds to the TRIMB/CCNB2 promoter, thereby promoting the replication and transcription of covalently closed circular DNA (cccDNA) and promoting cancer progression [36].